Researcher
Isabel Leroux-Roels
- Keywords:vaccine immunology, infection prevention, infection control, vaccinology
- Disciplines:Diagnostics, Medicinal products, Laboratory medicine, Bacteriology, Infectious diseases, Vaccinology, Virology
Affiliations
- Department of Diagnostic Sciences (Department)
Member
From1 Oct 2018 → Today - Department of Clinical chemistry, microbiology and immunology (Department)
Member
From1 Nov 2003 → 30 Sep 2018
Projects
1 - 2 of 2
- HIGH-THROUGHPUT, HIGH-SENSITIVITY AND COST-EFFECTIVE MONITORING OF INNATE AND ADAPTIVE IMMUNE RESPONSES AT SINGLE CELL LEVELFrom15 Dec 2022 → TodayFunding: BOF - scientific equipment program
- Rapid ex-vivo detection, quantification and characterisation of cell-mediated immune responses induced by natural infection or vaccination with SARS-CoV-2 orr other pathogens.From1 Apr 2021 → 31 Mar 2023Funding: IOF - technology validation in lab
Publications
21 - 30 of 45
- Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults : two clinical trials(2021)
Authors: Ilse De Coster, Isabel Leroux-Roels, Ananda S. Bandyopadhyay, Christopher Gast, Kanchanamala Withanage, Katie Steenackers, Philippe De Smedt, Annelies Aerssens, Geert Leroux-Roels, M. Steven Oberste, et al.
Pages: 39 - 50 - Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older : a randomized Phase III trial(2021)
Authors: S Pepin, JF Nicolas, H Szymanski, Isabel Leroux-Roels, T Schaum, M Bonten, G Icardi, A Shrestha, C Tabar, QHD00011 study team
Pages: 5475 - 5486 - Safety and immunogenicity of a new Sabin inactivated poliovirus vaccine candidate produced on the PER.C6 (R) cell-line : a phase 1 randomized controlled trial in adults(2021)
Authors: Isabel Leroux-Roels, Geert Leroux-Roels, Georgi Shukarev, Hanneke Schuitemaker, Conor Cahill, Richard de Rooij, Martin Struijs, Hester van Zeeburg, Jeanne-Marie Jacquet
Pages: 1366 - 1373 - Multidrug-resistant bacteria in ICU : fact or myth(2020)
Authors: Jan De Waele, Jerina Boelens, Isabel Leroux-Roels
Pages: 156 - 161 - ATP measurement as an objective method to measure environmental contamination in 9 hospitals in the Dutch/Belgian border area(2020)
Authors: A van Arkel, I Willemsen, L Kilsdonk-Bode, S Vlamings-Wagenaars, A van Oudheusden, Pascal De Waegemaeker, Isabel Leroux-Roels, M Verelst, E Maas, A van Oosten, et al.
- Nosocomial outbreak of extended-spectrum β-lactamase-producing Enterobacter cloacae among cardiothoracic surgical patients : causes and consequences(2019)
Authors: A Noël, C Vastrade, S Dupont, M de Barsy, TD Huang, Tom Van Maerken, Isabel Leroux-Roels, B Delaere, L Melly, B Rondelet, et al.
Pages: 54 - 60 - Caught on tape(2016)
Authors: LISBETH VANDENABEELE, Geertrui Coppens, Isabel Leroux-Roels, Pieter Hindryckx
Pages: 665 - 665 - Influenza vaccines: where do we stand? Where do we go? A bumpy but steady road upwards(2015)
Authors: Guus Rimmelzwaan, Isabel Leroux-Roels, S Gilbert, A Thomson
Pages: 7026 - 7028 - Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: randomised, controlled trials(2015)
Authors: Isabel Leroux-Roels, Jeanne-Marie Devaster, Geert Leroux-Roels, Vincent Verlant, Isabelle Henckaerts, Philippe Moris, Philippe Hermand, Pascale Van Belle, Jan T Poolman, Pierre Vandepapeliére, et al.
Pages: 577 - 584 - Bordetella pertussis seroprevalence in Belgian adults aged 20-39 years, 2012(2014)
Authors: K Huygen, C Rodeghiero, D Govaerts, Isabel Leroux-Roels, P Melin, M Reynders, S Van der Meeren, S Van den Wijngaert, D Pierard
Pages: 724 - 728